Why have BMS investors been anything but positive about acquiring 2seventy? The answer stems from uncertainty over how competitive Abecma will continue to be in the multiple myeloma space given an ...

Regina Toomey Bueno, former oncology admin at Garnet Health, had good insurance, lots of support, and 2 cancer diagnoses. She ...

Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...

In this episode of Targeted Talks, Alfred L. Garfall, discusses the phase 2 BMT CTN 1902 trial of idecabtagene vicleucel in ...

During a Case-Based Roundtable® event, Robert Z. Orlowski, MD, PhD, discussed the case of a patient who had progression of ...

Based on internal projections for demand, the two companies have approved about $150 million in additional investments to ...

March is Myeloma Awareness Month, a time to recognize the subtle but serious symptoms of multiple myeloma, including persistent fatigue, unexplained bone pain and anemia. Since diagnosis is often ...

The International Myeloma Foundation (IMF) is excited to announce that the 2nd annual Iceland Cycling Expedition (ICE)—a 6-night/7-day endurance fundraiser biking expedition —will take place from ...

An elderly patient who was initially suspected of having antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) was instead diagnosed with multiple myeloma, according to a case report ...

Genmab wisely chose not to pursue GEN3014 further, focusing instead on its existing pipeline projects. Click here to read an ...

Study reveals multiple high-risk genetic changes predict worse multiple myeloma outcomes across all treatments.

SkylineDx has published a new study marking a “significant advancement” in the understanding and identification of high-risk ...